BioSpace News Archive

The global Famciclovir API market size is estimated to be worth US$ 13 million in 2021 and is forecast to a readjusted size of US$ 15 million by 2030 with a CAGR of 2.3% during the forecast period 2022-2030.

The global Nuclease market size is estimated to be worth US$ 493.3 million in 2021 and is forecast to a readjusted size of US$ 817.9 million by 2030 with a CAGR of 7.4% during the forecast period 2022-2030.

The global Ceftriaxone Sodium market size is estimated to be worth US$ 264.2 million in 2021 and is forecast to a readjusted size of US$ 217.6 million by 2030 with a CAGR of -2.7% during the forecast period 2022-2030.

Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, has announced the closing of its $20 million financing round led by an investment partner of VDI shareholder Rainbow Medical.

According to Nova one advisor, the U.S. Fundus Camera market size was valued at US$ 130.16 Million in 2021 and is expected to hit US$ 191.80 Million by 2030, growing at a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030.

The U.S. Home Medical Equipment market size was valued at US$ 12.23 billion in 2021 and is expected to hit US$ 21.13 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.9% from 2022 to 2030.

The U.S. Cardiac Resynchronization Therapy market size was valued at US$ 983.3 Million in 2021 and is expected to hit US$ 1.45 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030.

Many cancer patients show no symptoms at early stages and receive diagnoses at advanced stages, which can drastically attenuate treatment effectiveness and decrease their quality of life.

The Japanese Plasmalogen Society (Office: Higashi-ku, Fukuoka, Japan; President: Yutaka Oomura) announced the research results that scallop-derived plasmalogens administered to college athletes improved sleep disorders, negative mood and mental concentration.

Canadian Hospital Specialties Limited completed the acquisitions of Stadco Polyproducts Inc. and Respan Products Inc. effective June 3rd 2022.